探讨米非司酮联合甲氨蝶呤保守治疗宫外孕临床治疗效果
及安全性
张晓玲
【期刊名称】《医学信息》 【年(卷),期】2016(029)014
【摘要】Objective To investigate mifepristone combined methotrexate conservative treatment of ectopic pregnancy clinical therapeutic effect and safety.Methods Our hospital of 50 cases of ectopic pregnancy patients,the patients were divided into control group and experimental group in accordance with the principle of random,25 cases in the control group given methotrexate therapy,while the experimental group of methotrexate therapy at the same time,combined therapy with mifepristone.Results The total effective rate was significantly higher than that of control group,P<0.05;Incidence of adverse reactions to the two groups has no statistical significance, >0.05).Conclusion In patients with ectopic pregnancy conservative treatment in clinical,mifepristone combined methotrexate curative effect is distinct,the low incidence of adverse reactions,worthy of clinical popularization and application.%目的：探讨米非司酮联合甲氨蝶呤保守治疗宫外孕的临床治疗效果及安全性。方法选择我院收治的部分宫外孕患者50例，按照随机原则将患者分成对照组和实验组各25例，对照组给予甲氨蝶呤治疗，实验组则在甲氨蝶呤治疗的同时，联合米非司酮治疗。结果实验组总有效率显著高于对照组，﹤0.05；两组不良
探讨米非司酮联合甲氨蝶呤保守治疗宫外孕临床治疗效果及安全性
